OrbusNeich (Stock Code: 6929) Schedules Board Meeting to Review Annual Results

Bulletin Express
03/02

OrbusNeich Medical Group Holdings Limited (Stock Code: 6929) has announced that its board of directors will convene on March 12, 2026. The agenda includes reviewing and approving the annual results for the fiscal year ended December 31, 2025, considering a final dividend if applicable, and discussing any other pending matters.

This announcement indicates that the company’s leadership, chaired by Mr. David Chien, will assess the performance of the past financial year, which concluded on December 31, 2025. The directors will also deliberate on the distribution of dividends, subject to final approval. The conclusions from this meeting are expected to be disclosed following the formal board review.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10